Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxaliplatin promotes siMAD2L2‑induced apoptosis in colon cancer cells
Lu Ma, Xin Li, Xiaopeng Zhao, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 3
Open Access | Times Cited: 12

Showing 12 citing articles:

Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches
Fakhria A. Al-Joufi, Aseem Setia, Mounir M. Salem‐Bekhit, et al.
Nanomaterials (2022) Vol. 12, Iss. 1, pp. 169-169
Open Access | Times Cited: 67
Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer
Chunlin Lin, Penghang Lin, Hengxin Yao, et al.
Cancer Letters (2024) Vol. 587, pp. 216712-216712
Open Access | Times Cited: 14
REV7: a small but mighty regulator of genome maintenance and cancer development
Lara R. Maggs, Mitch McVey
Frontiers in Oncology (2025) Vol. 14
Open Access
POGZ targeted by LINC01355/miR-27b-3p retards thyroid cancer progression via interplaying with MAD2L2
Jiancan Lu, Xinglu Zhou, Hongling Zhu, et al.
3 Biotech (2025) Vol. 15, Iss. 4
Closed Access
The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma
Zhiyuan Liu, Songtao Wang, Kuo Yu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
REV7 in Cancer Biology and Management
Yoshiki Murakumo, Yasutaka Sakurai, Takuya Kato, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1721-1721
Open Access | Times Cited: 9
Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model
Kuan‐Hui Li, Yi‐Yu Zhao, Hsin‐Lin Cheng, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 7, pp. 4058-4065
Closed Access | Times Cited: 2
REV7 is involved in outcomes of platinum‐based chemotherapy in pancreatic cancer by controlling the DNA damage response
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, et al.
Cancer Science (2023) Vol. 115, Iss. 2, pp. 660-671
Open Access | Times Cited: 5
Mitotic Arrest-Deficient 2 Like 2 (MAD2L2) Interacts with Escherichia coli Effector Protein EspF
Amin Tahoun, Hanem El-Sharkawy, Samar M. Moustafa, et al.
Life (2021) Vol. 11, Iss. 9, pp. 971-971
Open Access | Times Cited: 4
Anti-Cancer Mechanisms of Diarylpentanoid MS17 (1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one) in Human Colon Cancer Cells: A Proteomics Approach
Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Faridah Abas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3503-3503
Open Access
MAD2L2 as a novel prognostic biomarker and its correlation with immune infiltrates in glioma
Kaiqin Chen, He Li, Yongtai Chen, et al.
Deleted Journal (2024) Vol. 29, Iss. 1, pp. 215-228
Open Access
PSMD13 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
kexuan Wei, Chunxiang Lin, Jie Li, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top